Capital Impact Advisors, LLC Corcept Therapeutics Inc Transaction History

Capital Impact Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $559,930 - $728,706	26,537 New	26,537 $668,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $1.2 Million - $1.84 Million	-72,794 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$17.1 - $23.34 $774,459 - $1.06 Million	-45,290 Reduced 38.35%	72,794 $1.44 Million
Q2 2021 Aug 17, 2021	SELL	$19.97 - $24.43 $998,500 - $1.22 Million	-50,000 Reduced 29.75%	118,084 $2.6 Million
Q1 2021 May 18, 2021	SELL	$23.49 - $30.56 $216,483 - $281,640	-9,216 Reduced 5.2%	168,084 $4 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $73,924 - $102,660	7,312 Added 4.3%	177,300 $2.11 Million
Q4 2019 Feb 13, 2020	BUY	$12.06 - $16.96 $89,774 - $126,250	7,444 Added 4.58%	169,988 $2.06 Million
Q3 2019 Nov 14, 2019	SELL	$10.41 - $14.66 $217,839 - $306,775	-20,926 Reduced 11.41%	162,544 $2.37 Million
Q2 2019 Jul 19, 2019	SELL	$9.78 - $12.76 $99,990 - $130,458	-10,224 Reduced 5.28%	183,470 $2.04 Million
Q4 2018 Mar 08, 2019	BUY	$11.29 - $17.19 $459,559 - $699,718	40,705 Added 26.61%	193,694 $2.52 Million
Q3 2018 Oct 19, 2018	BUY	$12.27 - $15.65 $436,198 - $556,357	35,550 Added 30.27%	152,989 $2.1 Million
Q2 2018 Jul 25, 2018	BUY	$15.3 - $19.69 $660,057 - $849,446	43,141 Added 58.06%	117,439 $1.85 Million
Q1 2018 Apr 11, 2018	SELL	$14.59 - $25.5 $56,842 - $99,348	-3,896 Reduced 4.98%	74,298 $1.22 Million
Q3 2017 Jan 16, 2018	BUY	$12.3 - $19.3 $961,786 - $1.51 Million	78,194	78,194 $1.51 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.01B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.